PAG
ANIX icon

Private Advisor Group’s Anixa Biosciences ANIX Stock Holding History

Private Advisor Group’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6K Hold
10,221
– – ﹤0.01% 2486
2026
Q1 		$26.4K Hold
10,221
– – ﹤0.01% 2613
2025
Q4 		$31.9K Sell
10,221
-3,525
-26% -$14.4K ﹤0.01% 2543
2025
Q3 		$45.4K Buy
13,746
+2,132
+18% +$6.75K ﹤0.01% 2456
2025
Q2 		$38.3K Sell
11,614
-750
-6% -$2.14K ﹤0.01% 2363
2025
Q1 		$35.4K Buy
+12,364
New +$35.4K ﹤0.01% 2249
2020
Q3 		– Sell
-320
Closed -$1K – 1649
2020
Q2 		$1K Buy
+320
New +$664 ﹤0.01% 3660

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Private Advisor Group's ANIX Position: Q2 2026 in Review

Private Advisor Group held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 10,221 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2486.

Private Advisor Group first reported a position in ANIX in Q2 2020 and has held it in 7 quarters since. The position peaked at $45.4K in Q3 2025. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Private Advisor Group held 10,221 shares of Anixa Biosciences worth $28.6K as of Q2 2026.
  • Private Advisor Group left its Anixa Biosciences share count unchanged in Q2 2026.
  • Anixa Biosciences made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2486 holding.
  • Private Advisor Group first reported a position in Anixa Biosciences in Q2 2020 and has held it in 7 quarters since.
  • Private Advisor Group's Anixa Biosciences position peaked at $45.4K in Q3 2025.
  • 63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.